Foundational research points to new therapeutic strategies for an emerging cancer drug (opens in new tab)

Pancreatic cancer is one of the deadliest cancers and the third-leading cause of cancer-related death in the United States. While scientists continue searching for new therapies, advances can also come from understanding how existing drugs work. By uncovering the underlying biology, researchers can identify new ways to use existing drugs, improve their effectiveness and overcome barriers that have limited their clinical impact.